Two dead and nearly 2,000 new cases in Luxembourg!
A South African biotech company has announced that it has made the first messenger RNA vaccine against Covid-19 on the African continent, using Moderna sequencing, and that it will be ready for clinical trials in November. Cape Town, South Africa-based Afrigen Biologics and Vaccines is leading the pilot project, supported by the World Health Organization and the Covax initiative. The number of active cases, that is to say people who tested positive for Covid-19 in the last seven days, has quadrupled in one week in Polynesia, according to figures released on Friday by the Health Department. local. It listed 579 active cases on January 28, against 2,080 on February 4. The incidence rate now stands at 753 per 100,000 inhabitants, against 317 per 100,000 the previous week.